Oncolytics Biotech (ONCY) Prepaid Assets (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly Prepaid Assets came in at $1.1 million in Q4 2025, down 20.78% year-on-year from $1.3 million in Q4 2024, and down 10.57% on a QoQ basis from $1.2 million in Q3 2025.
Oncolytics Biotech (ONCY) Prepaid Assets (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 17 years of Prepaid Assets data on file, last reported at $1.1 million in Q4 2025.
- On a quarterly basis, Prepaid Assets fell 20.78% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 20.78% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 18.4% from the prior year.
- Prepaid Assets for Q4 2025 stood at $1.1 million, down from $1.2 million in the prior quarter.
- Over the last five years, Prepaid Assets for ONCY reached as high as $4.5 million in Q2 2023 and fell as low as $826151.2 in Q3 2024.
- Historically, Prepaid Assets has averaged $2.5 million across 5 years, with a median of $2.3 million in 2025.
- Across the five-year window, Prepaid Assets jumped 58.55% in 2022 and sank 76.56% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $2.2 million in 2021, then climbed by 1.19% to $2.2 million in 2022, then advanced by 6.99% to $2.4 million in 2023, then slumped by 43.41% to $1.3 million in 2024, then dropped by 20.78% to $1.1 million in 2025.
- Per Business Quant data, the three most recent Prepaid Assets figures were $1.1 million in Q4 2025, $1.2 million in Q3 2025, and $2.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 826,151.19 |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | 3.53 Mn |
| Jun 30, 2023 | 4.53 Mn |
| Mar 31, 2023 | 2.86 Mn |
| Dec 31, 2022 | 2.23 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 3.12 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Jun 30, 2021 | 3.66 Mn |
| Mar 31, 2021 | 2.28 Mn |